1. Home
  2. LNKB vs GNFT Comparison

LNKB vs GNFT Comparison

Compare LNKB & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNKB
  • GNFT
  • Stock Information
  • Founded
  • LNKB 2018
  • GNFT 1999
  • Country
  • LNKB United States
  • GNFT France
  • Employees
  • LNKB N/A
  • GNFT N/A
  • Industry
  • LNKB
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LNKB
  • GNFT Health Care
  • Exchange
  • LNKB Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • LNKB 261.4M
  • GNFT 216.7M
  • IPO Year
  • LNKB N/A
  • GNFT 2019
  • Fundamental
  • Price
  • LNKB $7.14
  • GNFT $4.48
  • Analyst Decision
  • LNKB Strong Buy
  • GNFT Strong Buy
  • Analyst Count
  • LNKB 1
  • GNFT 2
  • Target Price
  • LNKB $9.00
  • GNFT $10.00
  • AVG Volume (30 Days)
  • LNKB 118.6K
  • GNFT 13.7K
  • Earning Date
  • LNKB 10-27-2025
  • GNFT 09-22-2025
  • Dividend Yield
  • LNKB 4.19%
  • GNFT N/A
  • EPS Growth
  • LNKB 512.12
  • GNFT N/A
  • EPS
  • LNKB 1.03
  • GNFT N/A
  • Revenue
  • LNKB $122,594,000.00
  • GNFT $52,994,715.00
  • Revenue This Year
  • LNKB $18.38
  • GNFT $3.14
  • Revenue Next Year
  • LNKB N/A
  • GNFT N/A
  • P/E Ratio
  • LNKB $6.97
  • GNFT N/A
  • Revenue Growth
  • LNKB 42.32
  • GNFT N/A
  • 52 Week Low
  • LNKB $6.09
  • GNFT $2.55
  • 52 Week High
  • LNKB $7.98
  • GNFT $4.90
  • Technical
  • Relative Strength Index (RSI)
  • LNKB 48.19
  • GNFT 67.22
  • Support Level
  • LNKB $7.14
  • GNFT $4.25
  • Resistance Level
  • LNKB $7.75
  • GNFT $4.38
  • Average True Range (ATR)
  • LNKB 0.23
  • GNFT 0.29
  • MACD
  • LNKB -0.01
  • GNFT 0.08
  • Stochastic Oscillator
  • LNKB 25.00
  • GNFT 93.83

About LNKB LINKBANCORP Inc.

Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: